載入...
Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008
INTRODUCTION: Treatment for metastatic colorectal cancer (mCRC), employing various schedules, combinations, and regimens utilizing 5-fluorouracil (5-FU), irinotecan, oxaliplatin, capecitabine, bevacizumab, and cetuximab, currently achieves an overall survival that extends to approximately two years....
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3108637/ https://ncbi.nlm.nih.gov/pubmed/21694822 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|